Trend Results : Institute of Allergy


Related Searches

Blog Post Results (1-20 of 281)

FILTER RESULTS

San Diego Team Wins $ 6.9 Million Grant to Establish PrecISE Network Clinical Center

A team of physicians, scientists and biostatisticians from La Jolla Institute for Allergy and Immunology and UC San Diego School of Medicine joined forces across institutions to successfully compete for an $6.9 million grant to establish one of only 10 PrecISE Network Clinical Centers nationwide.

Gene-based Zika vaccine is safe and immunogenic in healthy adults

Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. Show More Summary

Trials show inactivated Zika virus vaccine is safe and immunogenic

(NIH/National Institute of Allergy and Infectious Diseases) The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials. Show More Summary

Gene-based Zika vaccine is safe and immunogenic in healthy adults

(NIH/National Institute of Allergy and Infectious Diseases) Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is safe and induces an immune response in healthy adults. Show More Summary

NIH and partners launch HIV vaccine efficacy study

(NIH/National Institute of Allergy and Infectious Diseases) The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. Show More Summary

Fighting the flu, year after year

WHAT: In a New England Journal of Medicine perspective, experts from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the World Health Organization (WHO) CollaboratingShow More Summary

NIH launches HIV prevention trial of long-acting injectable medication in women

(NIH/National Institute of Allergy and Infectious Diseases) The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and eastern Africa will...Show More Summary

Australia's flu season has U.S. health officials bracing for a bad winter — and wishing for a new vaccine

The flu season is just getting underway in North America, but if Australia’s experience with influenza is any guide, we’re in for a miserable winter. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, warned Wednesday that the United States could experience...

Fighting the flu, year after year

(NIH/National Institute of Allergy and Infectious Diseases) In a New England Journal of Medicine perspective, experts from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health,Show More Summary

NIAID scientists link cases of unexplained anaphylaxis to red meat allergy

(NIH/National Institute of Allergy and Infectious Diseases) While rare, some people experience recurrent episodes of anaphylaxis -- a life-threatening allergic reaction -- for which the triggers are never identified. Recently, researchers...Show More Summary

NIH scientists and collaborators find prion protein in skin of CJD patients

(NIH/National Institute of Allergy and Infectious Diseases) NIAID scientists and collaborators at Case Western Reserve University School of Medicine have detected abnormal prion protein in the skin of several people who died from Creutzfeldt-Jakob disease (CJD). Show More Summary

Three decades of responding to infectious disease outbreaks

(NIH/National Institute of Allergy and Infectious Diseases) In 1984, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, testified before Congress showing a world map annotated with a single emerging infectious disease threat, HIV/AIDS. Show More Summary

Dengue immunity can protect against Zika virus

(La Jolla Institute for Allergy and Immunology) A study published the Nov. 13, 2017, issue of Nature Communications by La Jolla Institute for Allergy and Immunology (LJI) investigator Sujan Shresta, Ph.D., now addresses interplay between dengue and ZIKV infections. Show More Summary

Cell phone-based microscope leads to possible strategy for treating river blindness

(NIH/National Institute of Allergy and Infectious Diseases) River blindness, or onchocerciasis, is a disease caused by a parasitic worm (Onchocerca volvulus) found primarily in Africa. Ivermectin is used to treat onchocerciasis. This treatment can be fatal when a person has high blood levels of another worm, Loa loa. Show More Summary

Experimental Ebola vaccines elicit year-long immune response

(NIH/National Institute of Allergy and Infectious Diseases) Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that last for at least one year. Show More Summary

$420,000 Grant Funds Study on What Makes Humans Susceptible to Zika

A Texas researcher has received a two-year, $420,000 grant from the National Institute of Allergy and Infectious Disease (NIAID) to study the mosquito-borne virus Zika. With the NIAID grant, Wu and his colleagues at Texas Tech University...Show More Summary

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

(NIH/National Institute of Allergy and Infectious Diseases) Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary from Anthony S. Show More Summary

Multiple research approaches are key to pandemic preparedness, NIAID officials say

(NIH/National Institute of Allergy and Infectious Diseases) Preparedness in the face of major disease outbreaks can save thousands of lives. A new article by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious...Show More Summary

Monoclonal Antibodies Against Zika Show Promise in Monkey Study

(NIH/National Institute of Allergy and Infectious Diseases) Using blood samples from an individual previously infected with Zika virus, NIAID-supported scientists, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection. Show More Summary

Professor says Southwest removal was from prejudice, not allergy

2 months agoNews : NY Daily News

Anila Daulatzai, who teaches at the Maryland Institute College of Art, was seen in a viral video last Tuesday.

Copyright © 2015 Regator, LLC